Has Rachael Touma received payments from drug or device companies?

Yes. Drug and device makers reported $5,085 in general payments to Rachael Touma across 270 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachael Touma did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachael Touma come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachael Touma

Psychiatric/Mental Health · Claremore, OKNPI 1598398133

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,703 and has fallen 62.7% since, to $635 in 2025.

$5,085in general payments, 2019–2025

Across 270 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
AbbVie$807
Supernus Pharmaceuticals, Inc.$723
Johnson & Johnson$586
Axsome Therapeutics, Inc.$417
Lundbeck LLC$395
plus $1K from 10 others

What the payments were for

Food & beverage$5,085100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	55	$1,010
AbbVie	60	$807
Supernus Pharmaceuticals, Inc.	35	$723
Johnson & Johnson	16	$586
Axsome Therapeutics, Inc.	7	$417
Lundbeck LLC	27	$395
Ironshore Pharmaceuticals Inc.	14	$258
Vanda Pharmaceuticals Inc.	18	$197
Takeda Pharmaceuticals U.S.A., Inc.	10	$173
Alkermes, Inc.	8	$170
Sunovion Pharmaceuticals Inc.	6	$131
Otsuka America Pharmaceutical, Inc.	6	$112
Teva Pharmaceuticals USA, Inc.	3	$50
Corium, LLC	3	$22
OWP Pharmaceuticals, Inc.	1	$19
Merck	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,085 in reported general payments places this provider in the 85th percentile of 231 psychiatric/mental health providers in Oklahoma.

See all psychiatric/mental health providers in Oklahoma →

Other psychiatric/mental health in Claremore

Jonathan LurzClaremore$6K
Sarah WoodyClaremore$5K
Meryl AaronEdmond$23K
Fernanda CooleyTulsa$16K
Amy BoggsNorman$15K
Amber BrownEdmond$15K
Sylvie MawohOklahoma City$14K
Nicole HolzerNorman$12K
Pramila TraxlerTulsa$12K
Sasha LounmalaMuskogee$10K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →